Zero Form News Today

US Food and Drug Administration US FDA has successfully completed the inspection of the multipurpose API manufacturing facility of Solara Active Pharma Scienc

The US Food and Drug Administration (FDA) completes inspection of Solara Active Pharma Sciences API manufacturing facility in Visakhapatnam, Andhra Pradesh, with no observations. Solara confirms compliance with FDA standards. The facility, dedicated to Ibuprofen API production, marks Solaras second successful FDA inspection. The company aims for global market expansion with FDA-approved facilities.

US FDA inspected the the multi-product facility between and found it to be in an “acceptable state of compliance”, the company said

Pokémon TCG Japan’s Ruler of the Black Flame, the basis for the next English-language set, includes a Palafin Illustration Rare.

USFDA clears Solara Active's Visakhapatnam facility. The US Food and Drug Administration has cleared Solara Active Pharma Sciences Ltd's new multipurpose active pharmaceutical ingredient manufacturing facility at Visakhapatnam, Andhra Pradesh, with no observation, the company said in an exchange filing.

Solara Active Pharma Sciences Ltd today announced that its new state-of-the-art multipurpose API manufacturing facility at Visakhapatnam, Andhra Pradesh completed successfully the inspection carried out by the US FDA.